Skip to main content

Zynerba Pharmaceuticals Inc. Common Stock (ZYNE)

About The Company

ZYNE Stock Market Logo

Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

IPO Year Sector Industry
2015 Health Care Biotechnology: Pharmaceutical Preparations

Zynerba Pharmaceuticals Inc. (ZYNE) Latest News

Company Contact & Address (ZYNE)

Corporate Headquarters Phone Website
United States
+1 484 581-7505 Official ZYNE Website

ZYNE Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ZYNE

Jobs & Employment at Zynerba Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs & Careers at Zynerba Pharmaceuticals Inc. (ZYNE)

Related & Similar Stock Symbols

PCN Stock Market Price & News


Pimco Corporate & Income Strategy Fund Common Stock

VNET Stock Market Price & News


VNET Group Inc. American Depositary Shares

XFLT Stock Market Price & News


XAI Octagon Floating Rate & Alternative Income Term …